Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
IES Holdings
IESC
$15.1B
| $14.8M | ﹤0.01% |
31,073
-1,542
| -5% | -$707K |
|
1702
Viking Therapeutics
VKTX
$3.87B
| $14.8M | ﹤0.01% |
454,063
-20,558
| -4% | -$661K |
|
1703
Impinj
PI
$5.28B
| $14.8M | ﹤0.01% |
143,782
-1,079
| -0.7% | -$144K |
|
1704
CleanSpark
CLSK
$3.1B
| $14.7M | ﹤0.01% |
1,733,171
-206,323
| -11% | -$2.21M |
|
1705
Denali Therapeutics
DNLI
$3.9B
| $14.7M | ﹤0.01% |
768,039
+5,952
| +0.8% | +$118K |
|
1706
Diamondrock Hospitality Co
DRH
$2.53B
| $14.7M | ﹤0.01% |
1,571,973
-25,649
| -2% | -$245K |
|
1707
Hilton Grand Vacations
HGV
$3.57B
| $14.7M | ﹤0.01% |
376,382
-4,548
| -1% | -$204K |
|
1708
Golar LNG
GLNG
$5.34B
| $14.7M | ﹤0.01% |
270,973
-7,435
| -3% | -$328K |
|
1709
Grab
GRAB
$14.8B
| $14.7M | ﹤0.01% |
4,003,254
-230,842
| -5% | -$979K |
|
1710
ICICI Bank
IBN
$107B
| $14.6M | ﹤0.01% |
565,583
-10,028
| -2% | -$294K |
|
1711
Sumitomo Mitsui Financial
SMFG
$167B
| $14.6M | ﹤0.01% |
739,781
+28,651
| +4% | +$602K |
|
|
PRMB
1712
Primo Brands
PRMB
$8.94B
| $14.6M | ﹤0.01% |
774,190
+26,541
| +4% | +$513K |
|
1713
Omnicell
OMCL
$1.7B
| $14.5M | ﹤0.01% |
433,454
+151,679
| +54% | +$6.35M |
|
1714
Applied Optoelectronics
AAOI
$12.7B
| $14.5M | ﹤0.01% |
170,958
+8,777
| +5% | +$560K |
|
1715
Artisan Partners
APAM
$2.99B
| $14.4M | ﹤0.01% |
396,626
-36,180
| -8% | -$1.48M |
|
1716
Flowers Foods
FLO
$1.59B
| $14.4M | ﹤0.01% |
1,770,355
+138,775
| +9% | +$1.39M |
|
1717
WisdomTree
WT
$3.46B
| $14.3M | ﹤0.01% |
985,511
+127,563
| +15% | +$1.97M |
|
1718
Cogent Biosciences
COGT
$6.58B
| $14.3M | ﹤0.01% |
372,796
-3,500
| -0.9% | -$129K |
|
1719
Capri Holdings
CPRI
$1.74B
| $14.3M | ﹤0.01% |
814,050
-3,842
| -0.5% | -$81.3K |
|
1720
SiriusPoint
SPNT
$2.76B
| $14.3M | ﹤0.01% |
665,602
-16,888
| -2% | -$348K |
|
1721
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.08B
| $14.3M | ﹤0.01% |
+248,700
| New | +$15M |
|
|
VISN
1722
Vistance Networks Inc
VISN
$2.66B
| $14.3M | ﹤0.01% |
786,673
-41,882
| -5% | -$764K |
|
1723
Park Hotels & Resorts
PK
$3.05B
| $14.3M | ﹤0.01% |
1,359,269
-38,398
| -3% | -$424K |
|
1724
NETSCOUT
NTCT
$2.88B
| $14.3M | ﹤0.01% |
449,331
-10,672
| -2% | -$310K |
|
|
DFTX
1725
Definium Therapeutics
DFTX
$5.73B
| $14.2M | ﹤0.01% |
752,922
+454,262
| +152% | +$7.71M |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.